GE Medical Systems has signed an exclusive multiyear agreement to supply American Diagnostic Medicine (ADM) with more than 40 PET and hybrid PET/CT imaging systems. The agreement includes GE's Discovery LS and Discovery VI, as well as its Advance NXi PET
GE Medical Systems has signed an exclusive multiyear agreement to supply American Diagnostic Medicine (ADM) with more than 40 PET and hybrid PET/CT imaging systems. The agreement includes GE's Discovery LS and Discovery VI, as well as its Advance NXi PET system. ADM has placed an initial order for six GE Discovery VI fused imaging systems, which will be installed in healthcare facilities in California, Florida, Illinois, and Texas. Privately held ADM runs hospital and healthcare facilities serving more than 100 healthcare organizations in the U.S. and worldwide. Imaging services include CT, MRI, and nuclear medicine.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.